Development and evaluation of cancer chemotherapy drug information cards (DIC)

Cancer patients often receive multiple drugs. It is often difficult for them to differentiate between signs and symptoms caused by cancer from those induced by medications. Drug information cards (DIC) may serve a useful purpose to circumvent some of these problems. Here I describe DICs and their evaluation by patients. A vast majority (85%) of patients approved of these cards, and 67% would recommend them to others. I conclude that DICs are useful for cancer patients, and their role in nononcologic patients needs evaluation.